Epigenetic disruption of the RARγ complex impairs its function to bookmark AR enhancer interactions required for enzalutamide sensitivity in prostate cancer
Sajad A. Wani(The Ohio State University), Moray J. Campbell(Cedars-Sinai Medical Center)
Cited by 1
Related Papers
The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide
|bioRxiv (Cold Spring Harbor Laboratory)|2023|4